Last update: Jan. 29, 2017

Sodium Cromoglicate

Very Low Risk for breastfeeding


Safe. Compatible.
Minimal risk for breastfeeding and infant.

It is administered by inhalation for the prevention of asthma and atopic rhinitis, orally for food allergies and topically on dermatologic and ophthalmologic conditions.

At latest update relevant published data on excretion into breast milk were not found.

There is a consensus among experts and scientific societies on considering Sodium Chromoglycate as compatible while breastfeeding (Nelson 2001, National Asthma Education 2004, Powrie 2006) because of a minimal absorption and low plasma levels appearing in the mother (AEMPS 2013, Davis 2015).

The small dose used and low plasma absorption of most inhaled preparations (either buccal or nasal), topically apply as ophthalmologic or dermatologic preparations, make it unlikely any passage in a significant amount into breastmilk.

WHO List of Essential Medicines 2002: compatible while breastfeeding.

Alternatives

We do not have alternatives for Sodium Cromoglicate since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Sodium Cromoglicate is also known as


Sodium Cromoglicate in other languages or writings:

Groups

Sodium Cromoglicate belongs to these groups or families:

Tradenames

Main tradenames from several countries containing Sodium Cromoglicate in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. <1 oral, 7-10 inhal, 0,03 oft. %
Molecular weight 512 daltons
Protein Binding 65 %
Tmax 0,2 hours
T1/2 1,3 hours

References

  1. Davis C. Cromolyn. Drug Summary. 2015 Full text (in our servers)
  2. AEMPS. Cromoglicato. Ficha técnica. 2013 Full text (in our servers)
  3. Powrie RO, Larson L, Miller M. Managing asthma in expectant mothers. Treat Respir Med. 2006 Abstract
  4. National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. Quick Reference from the Working Group Report on Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. 2004;1-12. 2004 Full text (link to original source) Full text (in our servers)
  5. National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. 2004;1-57. 2004 Full text (link to original source) Full text (in our servers)
  6. WHO / UNICEF. BREASTFEEDING AND MATERNAL MEDICATION Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs. Department of Child and Adolescent Health and Development (WHO/UNICEF) 2002 Full text (link to original source) Full text (in our servers)

Total visits

10,159

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche, España from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM